Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Efficacy of feverfew as prophylactic treatment of migraine.

Johnson ES, Kadam NP, Hylands DM, Hylands PJ.

Br Med J (Clin Res Ed). 1985 Aug 31;291(6495):569-73.

2.

Randomised double-blind placebo-controlled trial of feverfew in migraine prevention.

Murphy JJ, Heptinstall S, Mitchell JR.

Lancet. 1988 Jul 23;2(8604):189-92.

PMID:
2899663
3.
4.

Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study.

Shrivastava R, Pechadre JC, John GW.

Clin Drug Investig. 2006;26(5):287-96.

PMID:
17163262
5.

Efficacy of feverfew as prophylactic treatment of migraine.

Wind J, Punt J.

Br Med J (Clin Res Ed). 1985 Nov 23;291(6507):1508. No abstract available.

6.

Efficacy of feverfew as prophylactic treatment of migraine.

Waller PC, Ramsay LE.

Br Med J (Clin Res Ed). 1985 Oct 19;291(6502):1128. No abstract available.

7.

The efficacy and safety of feverfew (Tanacetum parthenium L.): an update of a systematic review.

Ernst E, Pittler MH.

Public Health Nutr. 2000 Dec;3(4A):509-14. Review.

PMID:
11276299
8.

The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study.

Pfaffenrath V, Diener HC, Fischer M, Friede M, Henneicke-von Zepelin HH; Investigators.

Cephalalgia. 2002 Sep;22(7):523-32.

PMID:
12230594
9.
10.

Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study.

Diener HC, Pfaffenrath V, Schnitker J, Friede M, Henneicke-von Zepelin HH.

Cephalalgia. 2005 Nov;25(11):1031-41.

PMID:
16232154
11.

Feverfew in rheumatoid arthritis: a double blind, placebo controlled study.

Pattrick M, Heptinstall S, Doherty M.

Ann Rheum Dis. 1989 Jul;48(7):547-9.

12.

Feverfew for preventing migraine.

Pittler MH, Vogler BK, Ernst E.

Cochrane Database Syst Rev. 2000;(3):CD002286. Review. Update in: Cochrane Database Syst Rev. 2004;(1):CD002286.

PMID:
10908545
13.

Feverfew as a preventive treatment for migraine: a systematic review.

Vogler BK, Pittler MH, Ernst E.

Cephalalgia. 1998 Dec;18(10):704-8. Review.

PMID:
9950629
14.

An extract of Petasites hybridus is effective in the prophylaxis of migraine.

Grossmann M, Schmidramsl H.

Int J Clin Pharmacol Ther. 2000 Sep;38(9):430-5.

PMID:
11020030
15.

Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial.

Tfelt-Hansen P, Standnes B, Kangasneimi P, Hakkarainen H, Olesen J.

Acta Neurol Scand. 1984 Jan;69(1):1-8.

PMID:
6367336
16.

Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.

Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM; BOTOX North American Episodic Migraine Study Group.

Headache. 2007 Apr;47(4):486-99.

PMID:
17445098
18.

Feverfew for preventing migraine.

Pittler MH, Ernst E.

Cochrane Database Syst Rev. 2004;(1):CD002286. Review.

PMID:
14973986
19.

Progress in the medicinal chemistry of the herb feverfew.

Groenewegen WA, Knight DW, Heptinstall S.

Prog Med Chem. 1992;29:217-38. Review. No abstract available.

PMID:
1475370
20.

Supplemental Content

Support Center